DARE
Dare Bioscience, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.72
+1.11%Leverage
- Debt / equity
- -12.08x
- Net debt / equity
- 10.45x
- Debt / assets
- 0.30x
- Debt / EBITDA
- -0.74x
- Net debt / EBITDA
- 0.64x
Liquidity & coverage
- Current ratio
- 0.99x
- Quick ratio
- 0.99x
- Cash ratio
- 0.75x
- Interest coverage
- -55.72x
- EBITDA / interest
- -46.08x
- Working capital
- -$236.5K
Cash & dividend
- FCF / debt
- -1.74x
- Cash flow / debt
- -1.67x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026